Chemfab Alkalis Ltd
Chemfab Alkalis Ltd Q1 FY27 Results & Presentation Highlights: Revenue ₹73.16 Cr, PAT ₹7.51 Cr
Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.
Based on Chemfab Alkalis Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Consolidated Q1FY27 Revenue from Operations: ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Quarterly EBITDA (Q1FY27, Consolidated): ₹10.13 crore - Year-on-year (Y-o-Y) change: -10.35% (from ₹11.30 crore in Q1FY26) - Operating EBITDA margin: 13.85% (up 150 bps Y-o-Y from 12.34%)
From Chemfab Alkalis Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Consolidated Q1FY27 Revenue from Operations: ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). (Page 7)
- Chemical Segment Q1FY27 Revenue: ₹67.41 crore, up 27.57% YoY (from ₹52.84 crore in Q1FY26). (Page 8)
- OPVC Segment Q1FY27 Revenue: ₹5.75 crore, down 85.14% YoY (from ₹38.70 crore in Q1FY26). (Page 9)
- ECU Realisations in Chlor-Alkali: Improved sequentially to ₹39,600/MT from ₹39,100/MT in Q4FY26 (Page 6, Page 5)
2 more points management made on revenue & sales performance
Profitability & Margins
See what Chemfab Alkalis Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Chlor-Alkali business:
- ₹56 crore invested in technology modernisation to improve power efficiency by July 2025 (completed Q3FY26).
- ₹15 crore invested in a 10 MW hybrid power project reducing power cost; supply started Q1 FY27 (operational from 25th May 2026).
- OPVC Pipes Business capacity expansion at Sri City:
- Scaling from 14,000 TPA (FY25) to 20,000 TPA (FY26) with new production lines.
- Additional lines planned: 5th line (Q2FY26, ₹27 crore), 6th line (Q3FY26, ₹28 crore), 7th line (Q2FY27, ₹30 crore).
- Total capex for lines 5-7 approximately ₹85 crore.
- Each line capacity: 2,500-3,000 TPA; payback ~2–2.5 years.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Chemfab Alkalis Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Chemfab Alkalis Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹75 Cr, net profit ₹0 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Chemfab Alkalis Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key investor presentation takeaways from Fine
- Gujarat Alkalies & Chemicals Ltd (Q1 FY27)
Quarterly revenue for Q4 FY26 is INR 1,144 Cr., up from INR 1,004 Cr. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q1 FY27 invest
- Amines & Plasticizers Ltd (Q1 FY27)
Q1FY27 Revenue from Operations: ₹150.53 Crores, a 7% year-on-year increase from Q1FY26 (₹140.29 Crores). Key investor presentation takeaways from Amines & Plast
- Sudarshan Pharma Industries Ltd (Q1 FY27)
Revenue from Operations for June 2026 quarter: ₹174.41 Cr (Page 39) . Key investor presentation takeaways from Sudarshan Pharma Industries Ltd's Q1 FY27 investo
Frequently Asked Questions
What were Chemfab Alkalis Ltd Q1 FY27 results?
Consolidated Q1FY27 Revenue from Operations: ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Quarterly EBITDA (Q1FY27, Consolidated): ₹10.13 crore - Year-on-year (Y-o-Y) change: -10.35% (from ₹11.30 crore in Q1FY26) - Operating EBITDA margin: 13.85% (up 150 bps Y-o-Y from 12.34%)
What is Chemfab Alkalis Ltd share price analysis?
Chemfab Alkalis Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹531 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chemfab Alkalis Ltd planning capital expenditure?
Chlor-Alkali business: - ₹56 crore invested in technology modernisation to improve power efficiency by July 2025 (completed Q3FY26).
Keep Chemfab Alkalis Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.